PubRank

Frank C Detterbeck

Author PubWeight™ 100.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012 8.71
2 Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006 5.09
3 Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 3.82
4 Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med 2007 3.39
5 Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 2.16
6 Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? J Thorac Oncol 2010 2.00
7 Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg 2012 1.99
8 Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010 1.94
9 Counterpoint: are limited resections appropriate in non-small cell lung cancer? No: don't overdo it, and don't get confused. Chest 2012 1.60
10 Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg 2011 1.59
11 Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol 2004 1.56
12 Helical computed tomography inaccuracy in the detection of pulmonary metastases: can it be improved? Ann Thorac Surg 2007 1.54
13 Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 1.50
14 Standard outcome measures for thymic malignancies. J Thorac Oncol 2010 1.39
15 Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004 1.37
16 The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database. Cancer 2007 1.21
17 The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol 2015 1.20
18 Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol 2012 1.18
19 Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol 2008 1.16
20 Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol 2011 1.16
21 The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 1.12
22 An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg 2011 1.08
23 New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther 2009 1.07
24 Lumping, splitting, and sorting. J Thorac Oncol 2007 1.01
25 Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer 2008 0.99
26 Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg 2013 0.98
27 The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 0.98
28 Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review. J Thorac Cardiovasc Surg 2011 0.95
29 A systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stage. J Thorac Oncol 2010 0.95
30 Multifocal right atrial myxoma and pulmonary embolism. Ann Thorac Surg 2003 0.95
31 Accuracy of helical CT in the detection of pulmonary metastases: is intraoperative palpation still necessary? Ann Thorac Surg 2004 0.94
32 Details and difficulties regarding the new lung cancer staging system. Chest 2010 0.92
33 Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay. Cancer 2011 0.90
34 Looking in from above and up from below: new vistas in thoracic surgery. Innovations (Phila) 2012 0.90
35 Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 2008 0.90
36 Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. J Thorac Oncol 2015 0.90
37 The fable of Babel and building a foundation for quality. J Thorac Oncol 2012 0.89
38 A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. J Thorac Oncol 2014 0.89
39 Minimally invasive oesophagectomy more expensive than open despite shorter length of stay. Eur J Cardiothorac Surg 2013 0.87
40 Screening for lung cancer: moving into a new era. Ann Intern Med 2013 0.85
41 Standard outcome measures for thymic malignancies. J Thorac Oncol 2011 0.85
42 Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival. Eur J Cardiothorac Surg 2013 0.85
43 Beliefs among physicians in the diagnostic and therapeutic approach to non-small cell lung cancer. J Thorac Oncol 2007 0.84
44 The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer. J Thorac Oncol 2008 0.84
45 Pediatric thymomas: report of two cases and comprehensive review of the literature. Pediatr Surg Int 2013 0.81
46 A modern definition of mediastinal compartments. J Thorac Oncol 2014 0.81
47 Correction of postpneumonectomy syndrome using a custom implant. BMJ Case Rep 2011 0.81
48 Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation. Mod Pathol 2004 0.81
49 Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. Ann Thorac Surg 2012 0.81
50 Lobectomy versus limited resection in T1N0 lung cancer. Ann Thorac Surg 2013 0.81
51 Of buffaloes, horseshoes, and having no connections. Ann Thorac Surg 2005 0.81
52 The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol 2014 0.80
53 Current status of lung cancer screening. Semin Thorac Cardiovasc Surg 2012 0.80
54 Assessment of real-time 3D visualization for cardiothoracic diagnostic evaluation and surgery planning. J Digit Imaging 2005 0.80
55 Learning curve to lymph node resection in minimally invasive esophagectomy for cancer. Innovations (Phila) 2014 0.80
56 Overview. J Thorac Oncol 2014 0.79
57 Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol 2014 0.79
58 Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cells. Cancer Lett 2006 0.79
59 Airway complications after pulmonary resection. Thorac Surg Clin 2006 0.79
60 Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database. J Surg Res 2013 0.78
61 Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities. Oncology (Williston Park) 2006 0.78
62 Advances in surgical techniques in non-small cell lung cancer. Semin Respir Crit Care Med 2013 0.78
63 Overdiagnosis during lung cancer screening: is it an overemphasised, underappreciated, or tangential issue? Thorax 2014 0.78
64 Approaching the patient with an anterior mediastinal mass: a guide for radiologists. J Thorac Oncol 2014 0.77
65 Chromosomal abnormalities in bronchial epithelium from smokers, nonsmokers, and lung cancer patients. Cancer Genet Cytogenet 2005 0.77
66 Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm. Ann Surg Oncol 2016 0.77
67 Pushing forward into the darkness, leaping, and landing securely: prognostication and adjuvant chemotherapy for lung cancer. Chest 2011 0.77
68 The lung cancer stage page: there when you need it--staginglungcancer.org. Chest 2012 0.76
69 Does an anecdote substantiate dogma? Ann Thorac Surg 2006 0.76
70 Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer. Chest 2009 0.76
71 Evolution and science, progress and change. Thorax 2007 0.75
72 Synchronous, separate, and similar. J Thorac Oncol 2010 0.75
73 Response. Chest 2013 0.75
74 More Opaque Than Clear: Reality Is Always Cloaked in Shades of Gray. Oncology (Williston Park) 2016 0.75
75 Life in the real world. Chest 2005 0.75
76 On plain language and going astray. J Thorac Oncol 2011 0.75
77 Relearning the lessons of the past: are we making progress? Ann Thorac Surg 2005 0.75
78 Radiofrequency ablation (RFA) of pulmonary metastases: technical success vs. actual benefit. Ann Surg Oncol 2010 0.75
79 Sublobar resection of ground glass opacity--great data, but can I have more? J Thorac Oncol 2011 0.75
80 Critical points when using vectors. J Clin Oncol 2009 0.75
81 Please lead, but don't mislead. Chest 2008 0.75
82 Sublobar resection: are the answers different or is it the questions? J Thorac Oncol 2010 0.75
83 The ABCs of LTX for BAC. J Thorac Cardiovasc Surg 2003 0.75
84 Response. Chest 2013 0.75
85 Lung cancer: is it node number or location?: Pardon me, but what is the question? Chest 2013 0.75
86 A systematic review but systematically confounded? J Thorac Oncol 2010 0.75
87 Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg 2006 0.75
88 Clearing up opacities. Chest 2014 0.75
89 Visceral Pleural Invasion: Crossing a (Thin) Line. Chest 2015 0.75
90 Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy. Oncology (Williston Park) 2006 0.75
91 Experience with thoracoscopic pneumonectomies at a single institution. Innovations (Phila) 2014 0.75
92 Innovations in thoracic surgery. Curr Opin Anaesthesiol 2013 0.75
93 Transcervical wedge resection after transcervical extended mediastinal lymphadenectomy. Innovations (Phila) 2014 0.75
94 Fulminant development of mega-aorta due to Takayasu's arteritis: case report and review of the literature. Vascular 2005 0.75
95 A phase I study of gemcitabine and docetaxel for advanced stage solid tumors. Cancer Invest 2003 0.75
96 Transient brachial plexus palsy: an unusual complication of paravertebral infusion of local anesthetic. Ann Thorac Surg 2010 0.75
97 Gemcitabine-based combinations as preoperative therapy in resectable non-small-cell lung cancer. Clin Lung Cancer 2003 0.75
98 Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma. Gynecol Oncol 2004 0.75
99 Letter to the Editor: Re: The Impact of Overdiagnosis on the Selection of Efficient Lung Cancer Screening Strategies. Int J Cancer 2017 0.75
100 Intrathoracic hemorrhage after placement of a subpleural catheter. JAAPA 2011 0.75
101 Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2017 0.75
102 Length of Stay From the Hospital Perspective: Practice of Early Discharge Is Not Associated With Increased Readmission Risk After Lung Cancer Surgery. Ann Surg 2017 0.75